|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2007-10-2
|
|
pubmed:abstractText |
Renal cell carcinoma (RCC) is one of the most drug-refractory cancers. The aim of this study is to discover a novel therapeutic target molecule for clear cell RCC (CCRCC), which accounts for the majority of RCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5703-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17908959-Aged,
pubmed-meshheading:17908959-Antineoplastic Agents,
pubmed-meshheading:17908959-Apoptosis,
pubmed-meshheading:17908959-Carcinoma, Renal Cell,
pubmed-meshheading:17908959-Drug Design,
pubmed-meshheading:17908959-Female,
pubmed-meshheading:17908959-Gene Expression Profiling,
pubmed-meshheading:17908959-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17908959-Humans,
pubmed-meshheading:17908959-Interferon Inducers,
pubmed-meshheading:17908959-Kidney Neoplasms,
pubmed-meshheading:17908959-Male,
pubmed-meshheading:17908959-Middle Aged,
pubmed-meshheading:17908959-Poly I-C,
pubmed-meshheading:17908959-Toll-Like Receptor 3
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.
|
|
pubmed:affiliation |
Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
